| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 53 |
| 1 | PREDNISONE | 22 |
| 2 | INFLIXIMAB | 21 |
| 3 | AZATHIOPRINE | 17 |
| 4 | VEDOLIZUMAB | 17 |
| 5 | METHOTREXATE SODIUM | 11 |
| 6 | METHOTREXATE | 10 |
| 7 | MESALAMINE | 9 |
| 8 | ADALIMUMAB-AATY | 8 |
| 9 | ADALIMUMAB-ADAZ | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LACTULOSE SOLUTION USP, 10 G/15 ML | 1 | 0.0099 |
| 1 | USTEKINUMAB-AUUB | 1 | 0.0057 |
| 2 | ETRASIMOD | 1 | 0.0006 |
| 3 | DICLOFENAC SODIUM AND MISOPROSTOL | 3 | 0.0005 |
| 4 | AZATHIOPRINE SODIUM | 1 | 0.0004 |
| 5 | ADALIMUMAB-AFZB | 1 | 0.0004 |
| 6 | MESALAMINE | 9 | 0.0003 |
| 7 | TOFACITINIB CITRATE | 4 | 0.0003 |
| 8 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 9 | CHOLESTYRAMINE | 3 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 40 |
| 1 | Corticosteroid [EPC] | 39 |
| 2 | Integrin Receptor Antagonist [EPC] | 18 |
| 3 | Aminosalicylate [EPC] | 17 |
| 4 | Purine Antimetabolite [EPC] | 17 |
| 5 | Interleukin-23 Antagonist [EPC] | 11 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 10 |
| 7 | Benzodiazepine [EPC] | 9 |
| 8 | Interleukin-12 Antagonist [EPC] | 9 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 9 | 0.0003 |
| 1 | Bile Acid Sequestrant [EPC] | 3 | 0.0002 |
| 2 | Prostaglandin E1 Analog [EPC] | 4 | 0.0002 |
| 3 | Integrin Receptor Antagonist [EPC] | 18 | 0.0002 |
| 4 | CD30-directed Immunoconjugate [EPC] | 2 | 0.0002 |
| 5 | Purine Antimetabolite [EPC] | 17 | 0.0002 |
| 6 | Aminosalicylate [EPC] | 17 | 0.0002 |
| 7 | GLP-2 Analog [EPC] | 2 | 0.0001 |
| 8 | Cephalosporin Antibacterial [EPC] | 1 | 0.0001 |
| 9 | Interleukin-23 Antagonist [EPC] | 11 | 0.0001 |